Publication Name	World Journal of Clinical Pediatrics
Manuscript ID	105731
Country	United States

Category	Pediatrics
Manuscript Type	Evidence Review
Article Title	Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease
Manuscript Source	Invited Manuscript
All Author List	Rahiya Rehman
Funding Agency and Grant Number
Corresponding Author	Rahiya Rehman, Assistant Professor, MD, Department of Pediatric Gastroenterology, Saint Louis University, 1465 S Grand Blvd, Saint Louis, MO 63108, United States. rahiya.rehman@health.slu.edu
Key Words	Pediatrics; Obesity; Metabolic dysfunction-associated steatotic liver disease; Glucagon-like peptide-1; Glucagon like peptide
Core Tip	Understanding the impact of glucagon-like peptide-1 analogs in the pediatric population is crucial, as these medications have the potential to address a significant treatment gap in childhood metabolic disorders. Their effects on weight regulation, insulin sensitivity, and liver health could offer long-term benefits, particularly in conditions such as obesity, type 2 diabetes, and metabolic dysfunction associated steatotic liver disease. Further research and clinical trials are needed to establish their safety, efficacy, and appropriate use in children.
Citation	Rehman R. Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease. World J Clin Pediatr 2025; In press

Received	2025-02-05 03:58
Peer-Review Started	2025-02-05 03:58
To Make the First Decision
Return for Revision	2025-02-18 07:38
Revised	2025-03-04 01:48
Second Decision	2025-04-14 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-04-14 09:40
Articles in Press	2025-04-14 09:40
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	2219-2808 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com